This demonstrated that SNRPD2 was generally overexpressed in tumors, was a putative prognostic biomarker in several cancers, and was associated with the activation of multiple gene sets that are considered hallmarks of oncogenesis and cancer progression. This evidence concerns the gene SNRPD2 and cancer.